(Q46202208)

20 December 2017

title

Antithrombotic effects of heparin oligosaccharides (English)

1 reference

20 December 2017

1 reference

Mattsson C

1

1 reference

20 December 2017

Palm M

series ordinal

2

1 reference

20 December 2017

Söderberg K

series ordinal

3

1 reference

20 December 2017

Holmer E

series ordinal

4

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

20 December 2017

Annals of the New York Academy of Sciences

published in

1 reference

20 December 2017

volume

556

1 reference

20 December 2017

page(s)

323-332

1 reference

20 December 2017

Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB22514.X

Discordance between the anti-Xa activity and the antithrombotic activity in an ultra-low molecular weight heparin fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB22514.X

Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB22514.X

Endothelial binding sites for heparin. Specificity and role in heparin neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB22514.X

Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1989.TB22514.X

10.1111/J.1749-6632.1989.TB22514.X

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

2735663

1 reference

20 December 2017